Table 3

Left ventricular histological parameters and their correlation with calibrated integrated backscatter values in 29 men and 11 women with coronary artery disease

VariableMean±SD or median (IQR) (n=40)rp Value
Total fibrosis (%)1.8 (1.2–2.6)*−0.32†0.047†
Interstitial fibrosis (%)1.3 (0.9–1.7)*−0.34†0.03†
Perivascular fibrosis ratio1.7 (1.1–2.3)*−0.12†0.49†
Arterioles/mm2 myocardium area0.8±0.4−0.020.90
Mean arteriolar diameter (μm)40±12−0.170.31
Arteriolar wall area/circumference ratio (μm2/μm)5.5±1.7−0.070.66
Cardiomyocyte width (μm)22±3−0.260.11
Capillary length density (mm/mm3)1106±4190.110.51
Diffusion radius (μm)18±4−0.120.47
Collagen I total fibrosis (%)5.0±3.90.060.74
Collagen I interstitial fibrosis (%)2.4±2.80.080.61
Collagen III total fibrosis (%)10.0±4.6−0.030.86
Collagen III interstitial fibrosis (%)7.4±4.0−0.020.92
Total collagen I/III ratio0.57±0.460.120.48
Interstitial collagen I/III ratio0.35±0.270.110.51
CML immunostaining arteriole media1.6±0.80.150.36
CML immunostaining arteriole intima1.8±0.70.070.65
RAGE immunostaining arteriole media0.6±0.7−0.140.41
RAGE immunostaining arteriole intima1.6±0.8−0.110.49
RAGE immunostaining capillaries1.3±1.00.070.68
  • *Median value and IQR given non-parametric distribution.

  • †Values derived from log-transformed data; n=40, except for perivascular fibrosis where n=38, and for capillary length density and diffusion radius where n=39; arteriolar wall area/circumference ratio was measured for arterioles with diameter (average of maximum and minimum diameter of each arteriole) of 20–80 μm.

  • CML, Nε-(carboxymethyl)lysine; RAGE, receptor for advanced glycation end products.